levodopa has been researched along with 4-s-cysteaminylphenol in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ito, S; Jimbow, K; Miura, T | 1 |
| Ito, S; Ito, Y; Jimbow, K | 1 |
| Fujita, K; Hasegawa, K; Inoue, S; Ito, S; Jiménez-Cervantes, C; Ozeki, H; Solano, F; Wakamatsu, K | 1 |
3 other study(ies) available for levodopa and 4-s-cysteaminylphenol
| Article | Year |
|---|---|
The in vivo antimelanoma effect of 4-S-cysteaminylphenol and its n-acetyl derivative.
Topics: Animals; Antineoplastic Agents; Carbidopa; Cell Division; Cysteamine; Cysteine; Drug Therapy, Combination; Evaluation Studies as Topic; Female; Kinetics; Levodopa; Melanoma, Experimental; Mice; Mice, Inbred Strains; Monophenol Monooxygenase; Neoplasm Transplantation; Phenols; Substrate Specificity | 1990 |
Depigmentation of black guinea pig skin by topical application of cysteaminylphenol, cysteinylphenol, and related compounds.
Topics: Animals; Cell Survival; Cysteamine; Cysteine; Epidermis; Guinea Pigs; Levodopa; Melanocytes; Skin Pigmentation; Vitiligo | 1987 |
Antimelanoma effect of 4-S-cysteaminylcatechol, an activated form of 4-S-cysteaminylphenol.
Topics: Animals; Antineoplastic Agents; Biotransformation; Cell Division; Cell Line; Cell Survival; Cysteamine; Dose-Response Relationship, Drug; Humans; Kinetics; Levodopa; Melanoma; Melanoma, Experimental; Membrane Glycoproteins; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Monophenol Monooxygenase; Oxidation-Reduction; Oxidoreductases; Proteins; Tumor Cells, Cultured | 1995 |